Brookstone Capital Management Boosts Holdings in Synopsys, Inc. $SNPS

Brookstone Capital Management raised its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS) by 282.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,457 shares of the semiconductor company’s stock after buying an additional 1,814 shares during the period. Brookstone Capital Management’s holdings in Synopsys were worth $1,212,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the business. Independence Bank of Kentucky grew its position in shares of Synopsys by 120.0% during the 2nd quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company’s stock valued at $28,000 after acquiring an additional 30 shares during the period. Saudi Central Bank bought a new stake in Synopsys during the first quarter valued at about $26,000. Princeton Global Asset Management LLC grew its holdings in Synopsys by 481.8% during the second quarter. Princeton Global Asset Management LLC now owns 64 shares of the semiconductor company’s stock valued at $33,000 after purchasing an additional 53 shares during the period. AlphaQuest LLC raised its stake in shares of Synopsys by 423.1% in the second quarter. AlphaQuest LLC now owns 68 shares of the semiconductor company’s stock worth $35,000 after buying an additional 55 shares during the period. Finally, DiNuzzo Private Wealth Inc. lifted its position in shares of Synopsys by 266.7% during the 3rd quarter. DiNuzzo Private Wealth Inc. now owns 77 shares of the semiconductor company’s stock valued at $38,000 after buying an additional 56 shares in the last quarter. 85.47% of the stock is currently owned by institutional investors.

Key Synopsys News

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Analysts/commentary note Synopsys’ recent bounce and argue the shares could be attractive after the pullback; these narratives can support buying interest as investors re-evaluate valuation and growth prospects. Is Synopsys (SNPS) an Attractive Investment Choice?
• Positive Sentiment: Separate coverage focuses on an ~18% share rebound, asking whether the recovery leaves the stock undervalued — this kind of coverage can support momentum buyers. Synopsys (SNPS): Has the Recent 18% Share Price Rebound Left the Stock Undervalued?
• Neutral Sentiment: Reported short-interest data appears to show a 0-share figure and 0.0 days-to-cover — likely a data glitch and not a reliable signal for positioning. Treat this as non-actionable until confirmed by an exchange/shorts report.
• Negative Sentiment: Multiple law firms have announced class-action suits or investor alerts alleging securities fraud tied to a sharp prior stock drop; firms are soliciting lead plaintiffs with a looming Dec. 30, 2025 deadline. The alleged class period is Dec. 4, 2024 through Sept. 9, 2025; some filings cite a ~36% decline as the basis for claims. This concentrated legal publicity increases headline risk, potential litigation costs, and investor uncertainty — factors that can pressure the stock. Representative notices: KSF / Charles Foti 96-Hour Deadline Alert — BFA: Suit after 36% stock drop — Levi & Korsinsky notice

Insider Buying and Selling

In other Synopsys news, CFO Shelagh Glaser sold 3,657 shares of the firm’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the transaction, the chief financial officer owned 17,842 shares in the company, valued at $8,221,058.34. This trade represents a 17.01% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Insiders own 0.62% of the company’s stock.

Synopsys Stock Performance

SNPS opened at $477.14 on Monday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.52 and a current ratio of 1.62. The stock has a market capitalization of $91.29 billion, a price-to-earnings ratio of 59.72, a PEG ratio of 3.97 and a beta of 1.16. The company has a fifty day moving average of $437.58 and a 200 day moving average of $503.62. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $651.73.

Synopsys (NASDAQ:SNPS) last released its quarterly earnings data on Wednesday, December 10th. The semiconductor company reported $2.90 EPS for the quarter, beating the consensus estimate of $2.79 by $0.11. The business had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. The business’s revenue was up 37.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $3.40 EPS. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. As a group, sell-side analysts forecast that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on SNPS shares. Zacks Research raised shares of Synopsys from a “strong sell” rating to a “hold” rating in a report on Monday, November 10th. KeyCorp increased their price objective on shares of Synopsys from $575.00 to $600.00 and gave the stock an “overweight” rating in a research note on Thursday, December 11th. Wells Fargo & Company lifted their target price on shares of Synopsys from $445.00 to $500.00 and gave the company an “equal weight” rating in a research note on Thursday, December 11th. Mizuho dropped their target price on shares of Synopsys from $700.00 to $600.00 and set an “outperform” rating for the company in a report on Thursday, September 11th. Finally, Citigroup assumed coverage on Synopsys in a report on Monday, November 24th. They set a “buy” rating and a $580.00 price target on the stock. Eleven analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $562.13.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.